البحث العلمي في دولة الإمارات

COVID-19 Vaccination Guidelines for MS Patients

نُشرت في الأربعاء، 25 أغسطس 2021

MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis

The MENACTRIMS practice guideline recommends COVID-19 vaccination for all multiple sclerosis (MS) patients, emphasizing that vaccines are effective and pose no additional risks. Patients on disease-modifying therapies (DMTs) may experience slightly reduced vaccine efficacy, but coordination of vaccine timing with certain DMTs can optimize protection. Despite vaccination, MS patients should continue preventive measures like wearing masks and social distancing. The guideline assures the safety of mRNA, non-replicating viral vector, inactivated virus, and protein vaccines, prioritizing patient protection against COVID-19.

البحوث ذات الصلة

اعرف المزيد
Switching from Fingolimod/Natalizumab to Cladribine Without Rebound
الجمعة، 1 ديسمبر 2023

Switching from Fingolimod/Natalizumab to Cladribine Without Rebound

اعرف المزيد
اعرف المزيد
Adherence Challenges for High-Efficacy MS Therapies
الجمعة، 22 مايو 2020

Adherence Challenges for High-Efficacy MS Therapies

اعرف المزيد
اعرف المزيد
Living with MS: A Biopsychosocial Perspective
الثلاثاء، 17 أغسطس 2021

Living with MS: A Biopsychosocial Perspective